Knockdown of GPC-3 was found to attenuate fibroblast growth factor 2 binding, a mitogen that promotes HCC cell proliferation and migration by activating downstream protein kinase pathways [40]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.